Header Logo

Connection

GEORGE CHOLANKERIL to Adult

Back to Details
This is a "connection" page, showing publications GEORGE CHOLANKERIL has written about Adult.
GEORGE CHOLANKERIL
Connection Strength
1.021
Adult
  1. The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults. J Pediatr Gastroenterol Nutr. 2024 Jul; 79(1):110-118.
    View in: PubMed
    Score: 0.048
  2. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras. Clin Infect Dis. 2023 02 18; 76(4):592-599.
    View in: PubMed
    Score: 0.045
  3. Comparable Survival for Hepatitis C-Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status. Clin Gastroenterol Hepatol. 2023 05; 21(5):1362-1364.e1.
    View in: PubMed
    Score: 0.042
  4. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
    View in: PubMed
    Score: 0.041
  5. NAFLD and HCC: Time to Bridge the Gap. Hepatology. 2021 11; 74(5):2336-2338.
    View in: PubMed
    Score: 0.040
  6. Association of Digestive Symptoms and Hospitalization in Patients With SARS-CoV-2 Infection. Am J Gastroenterol. 2020 07; 115(7):1129-1132.
    View in: PubMed
    Score: 0.037
  7. High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California. Gastroenterology. 2020 08; 159(2):775-777.
    View in: PubMed
    Score: 0.037
  8. Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States. Transplantation. 2019 01; 103(1):131-139.
    View in: PubMed
    Score: 0.033
  9. Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients. Clin Gastroenterol Hepatol. 2019 07; 17(8):1634-1636.
    View in: PubMed
    Score: 0.033
  10. Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States. J Gen Intern Med. 2018 09; 33(9):1423-1425.
    View in: PubMed
    Score: 0.033
  11. Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2018 06; 16(6):965-973.e2.
    View in: PubMed
    Score: 0.031
  12. Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents. Clin Gastroenterol Hepatol. 2018 03; 16(3):452-453.
    View in: PubMed
    Score: 0.031
  13. Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents. J Viral Hepat. 2017 12; 24(12):1194-1195.
    View in: PubMed
    Score: 0.030
  14. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Dig Dis Sci. 2017 10; 62(10):2915-2922.
    View in: PubMed
    Score: 0.030
  15. Portomesenteric venous thrombosis complicated by a haemorrhagic shock: a rare complication of laparoscopic gastrectomy. BMJ Case Rep. 2017 May 29; 2017.
    View in: PubMed
    Score: 0.030
  16. Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices. Clin Gastroenterol Hepatol. 2017 02; 15(2):313-315.
    View in: PubMed
    Score: 0.029
  17. Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C. Dig Dis Sci. 2016 09; 61(9):2505-15.
    View in: PubMed
    Score: 0.028
  18. Evolving burden of metabolic dysfunction-associated steatotic liver disease and its complications in a US nationwide healthcare system. Hepatol Commun. 2026 Jan 01; 10(1).
    View in: PubMed
    Score: 0.014
  19. Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease. Liver Transpl. 2026 Jan 01; 32(1):86-94.
    View in: PubMed
    Score: 0.013
  20. Association of High-Sensitivity Troponins in Metabolic Dysfunction-Associated Steatotic Liver Disease With All-Cause and Cause-Specific Mortality. Aliment Pharmacol Ther. 2025 Jun; 61(11):1785-1793.
    View in: PubMed
    Score: 0.013
  21. Statin Use Is Associated With Protection Against Acute Cholangitis in Patients With Primary Sclerosing Cholangitis: A Multicenter Retrospective Cohort Study. Clin Transl Gastroenterol. 2025 Apr 01; 16(4):e00816.
    View in: PubMed
    Score: 0.013
  22. A Three Decade Analysis of Trends in Length of Stay After Liver Transplantation. Prog Transplant. 2025 06; 35(2):55-63.
    View in: PubMed
    Score: 0.013
  23. Current Burden of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Among US Adults, 2017-2023. Aliment Pharmacol Ther. 2025 Mar; 61(5):891-894.
    View in: PubMed
    Score: 0.013
  24. Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023. Clin Mol Hepatol. 2025 Apr; 31(2):382-393.
    View in: PubMed
    Score: 0.013
  25. Is the Transplantation of Elderly and DCD Donors in Low MELD Recipients Justified: An Intent-to-treat Analysis. Transplantation. 2025 05 01; 109(5):823-831.
    View in: PubMed
    Score: 0.013
  26. Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018-2023. Clin Mol Hepatol. 2024 Oct; 30(4):756-770.
    View in: PubMed
    Score: 0.012
  27. Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality. J Gastroenterol Hepatol. 2024 Sep; 39(9):1950-1956.
    View in: PubMed
    Score: 0.012
  28. Steatotic liver disease-associated all-cause/cause-specific mortality in the United States. Aliment Pharmacol Ther. 2024 07; 60(1):33-42.
    View in: PubMed
    Score: 0.012
  29. Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel. JAMA Netw Open. 2023 12 01; 6(12):e2346380.
    View in: PubMed
    Score: 0.012
  30. Endogenous sex hormones and nonalcoholic fatty liver disease in US adults. Liver Int. 2024 02; 44(2):460-471.
    View in: PubMed
    Score: 0.012
  31. Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States. J Hepatol. 2024 02; 80(2):e79-e81.
    View in: PubMed
    Score: 0.012
  32. Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis. J Affect Disord. 2023 05 15; 329:184-191.
    View in: PubMed
    Score: 0.011
  33. Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis. Eur J Surg Oncol. 2023 07; 49(7):1242-1249.
    View in: PubMed
    Score: 0.011
  34. Trends in the Mortality of Biliary Tract Cancers Based on Their Anatomical Site in the United States From 2009 to 2018. Am J Gastroenterol. 2021 05 01; 116(5):1053-1062.
    View in: PubMed
    Score: 0.010
  35. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021 08; 41(8):1832-1840.
    View in: PubMed
    Score: 0.010
  36. Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018. J Gen Intern Med. 2022 01; 37(1):261-263.
    View in: PubMed
    Score: 0.010
  37. Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease. Hepatology. 2020 11; 72(5):1556-1568.
    View in: PubMed
    Score: 0.009
  38. Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality. Am J Gastroenterol. 2020 09; 115(9):1496-1504.
    View in: PubMed
    Score: 0.009
  39. Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018. Clin Gastroenterol Hepatol. 2021 07; 19(7):1499-1501.e2.
    View in: PubMed
    Score: 0.009
  40. Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2021 06; 19(6):1240-1247.e5.
    View in: PubMed
    Score: 0.009
  41. Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA. Dig Dis Sci. 2021 05; 66(5):1461-1476.
    View in: PubMed
    Score: 0.009
  42. Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol. 2020 04; 11(4):e00165.
    View in: PubMed
    Score: 0.009
  43. The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study. Drug Alcohol Depend. 2020 04 01; 209:107917.
    View in: PubMed
    Score: 0.009
  44. Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study. Dig Dis Sci. 2020 04; 65(4):990-1002.
    View in: PubMed
    Score: 0.009
  45. Depression is associated with non-alcoholic fatty liver disease among adults in the United States. Aliment Pharmacol Ther. 2019 09; 50(5):590-598.
    View in: PubMed
    Score: 0.009
  46. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017. Gastroenterology. 2019 10; 157(4):1055-1066.e11.
    View in: PubMed
    Score: 0.009
  47. Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers. Ann Hepatol. 2019 Sep - Oct; 18(5):679-684.
    View in: PubMed
    Score: 0.009
  48. Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States. Liver Int. 2019 07; 39(7):1335-1342.
    View in: PubMed
    Score: 0.009
  49. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. Hepatology. 2019 03; 69(3):1064-1074.
    View in: PubMed
    Score: 0.008
  50. Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2019 02; 31(2):149-156.
    View in: PubMed
    Score: 0.008
  51. Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis. Hepatol Int. 2019 Jan; 13(1):84-90.
    View in: PubMed
    Score: 0.008
  52. Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. Clin Gastroenterol Hepatol. 2019 10; 17(11):2379-2381.
    View in: PubMed
    Score: 0.008
  53. Early Liver Transplantation is a Viable Treatment Option in Severe Acute Alcoholic Hepatitis. Alcohol Alcohol. 2018 Nov 01; 53(6):716-718.
    View in: PubMed
    Score: 0.008
  54. Disparate Trends in Mortality of Etiology-Specific Chronic Liver Diseases Among Hispanic Subpopulations. Clin Gastroenterol Hepatol. 2019 07; 17(8):1607-1615.e2.
    View in: PubMed
    Score: 0.008
  55. Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016. J Viral Hepat. 2018 12; 25(12):1608-1616.
    View in: PubMed
    Score: 0.008
  56. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016. Gastroenterology. 2018 10; 155(4):1154-1163.e3.
    View in: PubMed
    Score: 0.008
  57. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. Dig Dis Sci. 2018 Jun; 63(6):1647-1653.
    View in: PubMed
    Score: 0.008
  58. Indications for antiviral therapy for chronic hepatitis B in pregnant mothers. BMJ Case Rep. 2016 Nov 15; 2016.
    View in: PubMed
    Score: 0.007
  59. The impact of age on nodal metastases and survival in gastric cancer. J Surg Res. 2016 05 15; 202(2):428-35.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.